Shigematsu Works Co., Ltd. (TYO:7980)
827.00
-4.00 (-0.48%)
Jul 17, 2025, 10:45 AM JST
Shigematsu Works Revenue
In the fiscal year ending March 31, 2025, Shigematsu Works had annual revenue of 14.11B JPY with 8.60% growth. Shigematsu Works had revenue of 4.42B in the quarter ending March 31, 2025, with 4.24% growth.
Revenue
14.11B
Revenue Growth
+8.60%
P/S Ratio
0.42
Revenue / Employee
36.18M
Employees
390
Market Cap
5.91B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 14.11B | 1.12B | 8.60% |
Mar 31, 2024 | 13.00B | 120.00M | 0.93% |
Mar 31, 2023 | 12.88B | 957.00M | 8.03% |
Mar 31, 2022 | 11.92B | -781.00M | -6.15% |
Mar 31, 2021 | 12.70B | 1.10B | 9.50% |
Mar 31, 2020 | Pro | Pro | Pro |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Chugai Pharmaceutical | 1,222.12B |
Takeda Pharmaceutical Company | 4,581.55B |
HOYA Corporation | 866.03B |
Daiichi Sankyo Company | 1,886.26B |
Terumo | 1,036.17B |
Otsuka Holdings | 2,393.18B |
Astellas Pharma | 1,912.32B |
Shionogi & | 438.27B |